The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Sinemet CR 50mg/200 mg Prolonged-release Tablets



Organon Pharma (Ireland) LimitedPA23198/004/005

Main Information

Trade NameSinemet CR 50mg/200 mg Prolonged-release Tablets
Active SubstancesLevodopa
Carbidopa
Dosage FormProlonged-release tablet
Licence HolderOrganon Pharma (Ireland) Limited
Licence NumberPA23198/004/005

Group Information

ATC CodeN04BA Dopa and dopa derivatives
N04BA02 levodopa and decarboxylase inhibitor

Status

License statusAuthorised
Licence Issued10/12/1991
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back